Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
At a trial in Georgia on Wednesday, three drug traffickers won a case brought by the family of a drug addict, accusing the company of selling drugs.
Read Full NewsAD109 Yields Numerically Greater OSA Improvements in Postmenopausal Women
CHEST 2026: Day 3 Recap — 6 Headlines to Know
Downar outlines the randomized trial needed to confirm optimal TMS dosing and addresses a safety ceiling on total pulses.
The chief research and medical affairs officer at the National MS Society discussed AI-enabled imaging, biomarkers of progression, women's health across the lifespan, and the Society's Campaign to End MS.
One-year data from the phase 3 AQUARELLE study found that divozilimab, an anti-CD20 antibody, reduced relapse risk in patients with neuromyelitis optica spectrum disorder.
Early phase 1 data in 3 patients suggest CTA313, an allogeneic CD19/BCMA CAR-T, may stabilize disability with a manageable safety profile in progressive MS.
Fast Track status covers AV-1959R, an investigational amyloid-beta vaccine, for preventing Alzheimer disease in cognitively unimpaired adults with amyloid pathology.
1.
A new way to measure suicide risk?
2.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
3.
Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum
4.
The Growing Role of AI in Cancer Treatment
5.
Race, Geography Linked to Gaps in Prostate Cancer Care
1.
Bridging Heart and Cancer Care: The Essential Framework of a Modern Cardio-Oncology Program
2.
Coagulation Factor Consumption During Severe Inflammation: Mechanisms, Clinical Implications, and Advances
3.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
4.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
5.
Everything You Need to Know About CA 19-9 and Cancer Diagnosis
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Managing Common Side Effects During Cancer Treatment
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
4.
Updates on Standard V/S High Risk Myeloma Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge